Efficacy of immune checkpoint inhibitors plus platinum-based chemotherapy as 1st line treatment for patients with non-small cell lung cancer harboring HER2 mutations: Results from LC-SCRUM-Asia

Yuki Kato, Hibiki Udagawa, Shingo Matsumoto, Hiroki Izumi, Y. Ohe, Terufumi Kato, Kazumi Nishino, Shingo Miyamoto, Sachiko Kawana, Kenichi Chikamori, Masato Shingyoji, Yuki Sato, Yuji Takada, Ryo Toyozawa, Koichi Azuma, Yu Tanaka, Tetsuya Sakai, Yuji Shibata, Eri Sugiyama, Kaname Nosaki, Yoshitaka Zenke, Shigeki Umemura, Kiyotaka Yoh, Masahiro Seike, Kōichi Goto